Cardinal Health, Inc.

CAH

US14149Y1082

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 14:30:18 27/06/2024 BST			5-day change	1st Jan Change
100.8 ^USD	-0.25%		-2.87%	+0.30%

06-14	Merit Medical is recalling unauthorized plastic syringes, US FDA says	RE
06-14	Deutsche Bank Adjusts Cardinal Health Price Target to $115 From $110	MT

Cardinal Health, Inc. Provides Earnings Guidance for the Year 2024

January 09, 2024 at 10:15 pm

Cardinal Health, Inc. provided earnings guidance for the year 2024. For the year, the company expectations for fiscal '24, the company just increased again further to the top end, which would bring to over 20% growth in EPS this year.

Latest news about Cardinal Health, Inc.

Merit Medical is recalling unauthorized plastic syringes, US FDA says	06-14	RE
Deutsche Bank Adjusts Cardinal Health Price Target to $115 From $110	06-14	MT
Top law firms in US opioid lawsuits to get hundreds of millions in fees	06-07	RE
Transcript : Cardinal Health, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 08:00 AM	05-29
Baird Adjusts Price Target on Cardinal Health to $129 From $128	05-29	MT
JPMorgan Adjusts Cardinal Health Price Target to $111 From $119	05-17	MT
Argus Adjusts Price Target on Cardinal Health to $115 From $120	05-15	MT
Transcript : Cardinal Health, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM	05-14
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024	05-07	CI
Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116	05-07	MT
Jefferies Cuts Cardinal Health's Price Target to $105 From $110	05-06	MT
Wells Fargo Raises Cardinal Health's Price Target to $95 From $94	05-03	MT
Baird Adjusts Price Target on Cardinal Health to $128 From $134	05-03	MT
Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118	05-02	MT
Transcript : Cardinal Health, Inc., Q3 2024 Earnings Call, May 02, 2024	05-02
Cardinal Health Posts Higher Fiscal Q3 Non-GAAP Earnings, Revenue; Raises Fiscal 2024 Earnings Guidance	05-02	MT
Earnings Flash (CAH) CARDINAL HEALTH Reports Q3 Revenue $54.91B, vs. Street Est of $56.11B	05-02	MT
Earnings Flash (CAH) CARDINAL HEALTH Posts Q3 EPS $2.08, vs. Street Est of $1.95	05-02	MT
Cardinal Health, Inc. Provides Preliminary Earnings Guidance for Fiscal Year 2025	05-02	CI
Cardinal Health, Inc. Raises Its Earnings Guidance for Fiscal Year 2024	05-02	CI
Cardinal Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-02	CI
Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024	05-02	CI
Futures climb as Fed allays rate-hike worries	05-02	RE
Wells Fargo Adjusts Cardinal Health Price Target to $94 From $96	04-29	MT
US FDA sends warning to Cardinal Health for marketing unapproved devices	04-25	RE

Chart Cardinal Health, Inc.

Duration

Period

More charts

Company Profile

Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.

Sector

Pharmaceuticals

Calendar

30/06/2024 - Détachement de

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Cardinal Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

101.1 USD

Average target price

112.5 USD

Spread / Average Target

+11.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CARDINAL HEALTH, INC.	+0.30%	24.62B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.70%	8.75B
SINOPHARM GROUP CO. LTD.	+0.49%	8.35B
HUADONG MEDICINE CO., LTD	-28.87%	7.1B
H. LUNDBECK A/S	+16.54%	5.25B
GALENICA AG	+2.41%	4.1B
EBOS GROUP LIMITED	-8.90%	3.8B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-7.62%	3.39B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+9.36%	3.25B
MEDIPAL HOLDINGS CORPORATION	+7.33%	3.18B

Pharmaceuticals Wholesale